Castle Biosciences, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
49.50
|
|
Average Rating
|
4.88
|
|
# Strong Buys
|
7
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.88
|
-0.77
|
0.11
|
12.50%
|
|
2022-06-30
|
-0.76
|
-0.06
|
0.70
|
92.11%
|
|
2022-03-31
|
-0.71
|
-0.97
|
-0.26
|
-36.62%
|
|
2021-12-31
|
-0.47
|
-0.25
|
0.22
|
46.81%
|
|
2021-09-30
|
-0.40
|
-0.47
|
-0.07
|
-17.50%
|
|
2021-06-30
|
-0.37
|
-0.35
|
0.02
|
5.41%
|
|
2021-03-31
|
-0.23
|
-0.17
|
0.06
|
26.09%
|
|
2020-12-31
|
-0.12
|
-0.23
|
-0.11
|
-91.67%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.80
|
|
2021-12-31
|
-1.24
|
|
2020-12-31
|
-0.51
|
|
2019-12-31
|
-2.11
|